SCHEMBL11920719

SCHEMBL11920719

Cc1cccc(C[C@@H](C)NC(=O)C2(NC(=O)c3cnccn3)CC2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.47
SMN1; SMN2 Q16637 4/20 0.43
ACACB O00763 1/20 0.42
HTT P42858 1/20 0.41
PSMB8 P28062 6/20 0.41
PSMB9 P28065 6/20 0.41
PSMB6 P28072 6/20 0.41
PSMB5 P28074 6/20 0.41
PSMB10 P40306 6/20 0.41
CTSL P07711 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LONP1 P36776 6/20 0.40
PSMB11 A5LHX3 5/20 0.40
PSMA7 O14818 5/20 0.40
PSMB1 P20618 5/20 0.40
PSMA1 P25786 5/20 0.40
PSMA2 P25787 5/20 0.40
PSMA3 P25788 5/20 0.40
PSMA4 P25789 5/20 0.40
PSMA5 P28066 5/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11921045 0.89 SMN1; SMN2 (0.53) CNR1SMN1; SMN2ACACBHTTPSMB8
SCHEMBL464435 0.88 PSMB5 (0.54) CNR1SMN1; SMN2PSMB8PSMB9PSMB6
SCHEMBL11920816 0.78 CTSB (0.51) CNR1SMN1; SMN2ACACBHTTCTSL
SCHEMBL12180708 0.77 PSMB5 (0.53) CNR1SMN1; SMN2PSMB8PSMB9PSMB6
SCHEMBL3081564 0.77 PSMB5 (0.53) CNR1SMN1; SMN2PSMB8PSMB9PSMB6
SCHEMBL3744717 0.76 PSMB5 (0.68) PSMB8PSMB9PSMB6PSMB5PSMB10
SCHEMBL21975356 0.75 CTSL (0.59) PSMB8PSMB9PSMB6PSMB5PSMB10
SCHEMBL20095238 0.73 CTSL (0.64) SMN1; SMN2HTTPSMB8PSMB9PSMB6
SCHEMBL11933676 0.73 CTSL (0.64) SMN1; SMN2HTTPSMB8PSMB9PSMB6
SCHEMBL464428 0.72 LONP1 (0.64) PSMB8PSMB9PSMB6PSMB5PSMB10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2212334-B1 PROTEASOME INHIBITORS MILLENNIUM PHARM INC (US) 2012-08-15 EP disclosed